In all included studies, the AKI risk-ratio (RR) was below 1 in patients undergoing intensified insulin therapy (0.74 [24], 0.66 [23], 0.15 [27], 0.25 [26], and 0.67 [25]). The gene discussed is INS; the disease is acute kidney injury.